This is not a NASA Website. You might learn something. It's YOUR space agency. Get involved. Take it back. Make it work - for YOU.
Astronauts

Astronaut Meds Go Commercial

By Keith Cowing
October 12, 2012
Filed under , ,


NASA Signs Agreement to Develop Nasal Spray for Motion Sickness, NASA (with full text of Space Act Agreement)
“Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With a precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.”
Epiomed and NASA Sign Space Act Agreement for INSCOP, an Intra-nasal Scopolamine Product
“Epiomed will take responsibility for further development and commercialization of INSCOP, assisted by NASA-HH&P (Human Health & Performance Directorate) technology, and assume sponsorship of the IND (Investigational New Drug) from NASA under the SAA.”

NASA Watch founder, Explorers Club Fellow, ex-NASA, Away Teams, Journalist, Space & Astrobiology, Lapsed climber.